ArticleNPJ Parkinson's disease2026
Allergic disease as a risk factor for Parkinson's disease: a possible role of eosinophil.
Article in NPJ Parkinson's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neuroinflammation is central to Parkinson's disease (PD) pathogenesis and allergic inflammation may contribute to PD risk, but evidence is limited. Using the Korean National Health Insurance Service database, we conducted a cohort study of 5,036,518 adults aged ≥40 years who underwent health examination in 2009 and identified incident PD from 2010 to 2019, excluding prior PD. Asthma, allergic rhinitis, and atopic dermatitis were defined by ICD-10 codes and healthcare utilization, and severity by annual outpatient visits. Cox proportional hazards models estimated hazard ratios (HRs) adjusting for demographics, lifestyle, and comorbidities. We compared eosinophil and neutrophil counts between 234 hospital-based PD patients and 468 controls. During follow-up, 44,621 PD cases occurred (0.9/1000 person-years). PD incidence was increased in asthma (HR 1.16; 95% CI 1.07-1.24) and allergic rhinitis (HR 1.18; 95% CI 1.14-1.22), but not atopic dermatitis. Risk increased with multiple allergic conditions (p
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.